France Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

France Pharmaceuticals and Healthcare Report Q3 2013 Jul 24th 2013, 00:00, by jayshree Executive Summary BMI View: In line with our view that France will miss its fiscal deficit target of 3.0% of GDP in 2013 (and we maintain our forecast of 3.5%) we expect the government to engage in more concerted fiscal consolidation over the coming quarters – with a heavy focus on the pharmaceuticals and healthcare sector. Headline Expenditure Projections ? Pharmaceuticals: EUR34.17bn (US$43.40bn) in 2012 to EUR32.94bn (US$40.19bn) in 2013; -3.6% in local currency terms and -7.4% in US dollar terms. ? Healthcare: EUR239.29bn (US$303.90bn) in 2012 to EUR243.95bn (US$297.61bn) in 2013; +1.9% in local currency terms and -2.1% in … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=108317. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/france-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions